Find comprehensive information on liver metastases diagnosis, including clinical documentation, medical coding (ICD-10 C78.7, C80.0), and healthcare guidelines. Learn about symptoms, staging, treatment options, and prognosis for secondary liver cancer. Explore resources for patients, physicians, and healthcare professionals seeking accurate and up-to-date information on liver metastases management.
Also known as
Secondary malignant neoplasm of liver
Indicates cancer that has spread to the liver from another primary site.
Malignant neoplasms of ill-defined sites
Used when the specific site of a secondary metastasis is unknown but suspected.
Malignant neoplasms
Covers a wide range of cancers, including potential primary sites for liver metastases.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the liver metastasis primary?
Yes
Coding error: Metastasis cannot be primary. Review diagnosis.
No
Primary site known?
When to use each related code
Description |
---|
Liver Metastases |
Hepatocellular Carcinoma |
Cholangiocarcinoma |
Coding liver metastases without documenting the primary cancer site leads to inaccurate coding and claims.
Lack of proper clinical documentation supporting the diagnosis of liver metastases can cause audit issues.
Failing to specify laterality (right, left, or bilateral) when clinically relevant affects coding specificity and reimbursement.
Patient presents with suspected liver metastases. Clinical presentation includes (patient-specific symptoms e.g., abdominal pain, right upper quadrant discomfort, fatigue, weight loss, jaundice, hepatomegaly). Relevant medical history includes (primary cancer diagnosis e.g., colorectal cancer, breast cancer, lung cancer) diagnosed on (date). Physical examination reveals (relevant findings e.g., palpable liver mass, ascites). Laboratory findings show (relevant abnormalities e.g., elevated liver function tests, elevated tumor markers such as CEA, CA 19-9, AFP). Imaging studies including (CT abdomen, MRI abdomen, PET scan) demonstrate multiple hepatic lesions consistent with metastatic disease. Diagnosis of liver metastases secondary to (primary cancer) is confirmed. The patient was counseled on prognosis and treatment options, including (systemic chemotherapy, targeted therapy, immunotherapy, hepatic arterial infusion therapy, radioembolization, surgical resection if applicable, palliative care). Treatment plan will be individualized based on the patient's performance status, extent of disease, and primary tumor type. Referral to (oncology, hepatology, palliative care, surgery) is made. Follow-up scheduled in ( timeframe) to monitor treatment response and manage potential complications such as liver failure, portal hypertension, and ascites.